Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| PROJ-03672 | Other Identifier | VA Ann Arbor Healthcare System |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| VA Ann Arbor Healthcare System | FED |
Not provided
Not provided
Not provided
This project will pilot-test and obtain stakeholder input on a telehealth-delivered substance use disorder (SUD) care model (with initial engagement and ongoing MI-CBT treatment) with the goal of increasing treatment utilization and improving outcomes for rural and non-rural Veterans with SUDs.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| MI-CBT Teletx | Experimental | The intervention consists of an initial 30-60 min phone-delivered Engagement session that focuses on MI to help participants build self-efficacy and motivation to engage and to empower them to plan change and use Elicit-Provide-Elicit (EPE) to address treatment barriers (e.g., stigma, appeal, accessibility). Participants will then complete up to 8 ~50 minute Teletx weekly sessions via videoconference (or phone if needed). The intervention is highly patient-centered, by meeting and assessing patients where they are including in their unique context (i.e. rural community), helping them identify reasons and motivations for change, and centered around their goals (e.g. substance use reduction or abstinence). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| VetReach | Behavioral | Telehealth-delivered MI-CBT substance use disorder care model |
|
| Measure | Description | Time Frame |
|---|---|---|
| Feasibility of the intervention (engagement) | Percent (%) of participants engaging in the intervention (at least 3 completed sessions) | 8 weeks |
| Acceptability of the telehealth intervention | Study-specific acceptability rating completed by participants (% with a positive rating, higher % is better) | 2 months |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Change in substance consumption | Substance use/consumption will be assessed using the 30-day Timeline Follow-Back (TLFB). The TLFB will capture information on the frequency and quantity of substance use, with total consumption calculated. | baseline, 8 weeks post-baseline |
| Change in frequency of substance use as reported on the Timeline Follow-Back (TLFB) |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Lewei Lin, MD | VA Ann Arbor Healthcare System, Ann Arbor, MI | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| VA Ann Arbor Healthcare System, Ann Arbor, MI | Ann Arbor | Michigan | 48105-2303 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| ICF | No | No | Yes | Informed Consent Form | Dec 13, 2018 | Aug 8, 2025 | ICF_000.pdf |
Not provided
| ID | Term |
|---|---|
| D019966 | Substance-Related Disorders |
| ID | Term |
|---|---|
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Based on frequency and quantity, higher scores indicate worse outcome. |
| baseline, 8 weeks post-baseline |